Previous close | 5.18 |
Open | 4.10 |
Bid | 0.00 |
Ask | 6.10 |
Strike | 210.00 |
Expiry date | 2026-12-18 |
Day's range | 4.10 - 5.18 |
Contract range | N/A |
Volume | |
Open interest | 5 |
Vertex Pharmaceuticals ( NASDAQ:VRTX ) First Quarter 2024 Results Key Financial Results Revenue: US$2.69b (up 13% from...
Vertex stock advanced Tuesday as analysts debated the company's pain drug with one saying it could eventually generate $11.4 billion in sales.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript May 6, 2024 Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.76, expectations were $4.07. Vertex Pharmaceuticals Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome […]